Robust Trading Volumes and Value Turnover
On the trading day, Artemis Medicare recorded a total traded volume of 67.81 lakh shares, translating into a substantial traded value of ₹247.56 crores. This high value turnover places the stock among the top equity performers in terms of market activity, reflecting heightened investor engagement. The stock opened at ₹346.0, marking a significant gap-up of 10.16% from the previous close of ₹332.7, and touched an intraday high of ₹374.6 before settling at ₹367.6 as of 10:40 AM IST.
The narrow intraday trading range of ₹1.15 around the weighted average price suggests that most volume was concentrated near the lower price levels, indicating strong buying interest at these prices. This price action, combined with the stock trading above all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), underscores a sustained bullish momentum.
Institutional Interest and Delivery Volumes
Despite the surge in volume, delivery volumes on 24 Sep stood at 1.16 lakh shares, reflecting a 13.2% decline compared to the five-day average delivery volume. This divergence suggests that while trading volumes have spiked, a significant portion of the activity may be driven by short-term traders or institutional participants engaging in large order flows rather than retail investors holding shares for the long term.
Artemis Medicare’s liquidity profile remains adequate, with the stock capable of supporting trade sizes up to ₹0.19 crore based on 2% of the five-day average traded value. This liquidity ensures that institutional investors can execute sizeable trades without excessive market impact, further attracting large-scale participation.
Market Capitalisation and Sector Performance
With a market capitalisation of approximately ₹5,791.63 crores, Artemis Medicare is classified as a small-cap stock within the hospital sector. On the day of the surge, the stock outperformed its sector by 11.12%, while the broader Sensex remained nearly flat with a marginal 0.03% gain. This relative outperformance highlights the stock’s growing appeal amid a generally subdued market environment.
The hospital sector itself experienced a modest decline of 1.08% on the day, making Artemis Medicare’s rally even more noteworthy as it bucks the sector trend. This divergence may be attributed to company-specific developments or positive sentiment driven by recent upgrades and improved fundamentals.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Mojo Score Upgrade and Analyst Sentiment
Artemis Medicare Services Ltd has recently seen its MarketsMOJO Mojo Grade upgraded from Hold to Buy on 8 Jun 2026, reflecting an improved outlook based on fundamental and technical factors. The company’s Mojo Score stands at a robust 78.0, signalling strong buy sentiment among analysts and market participants.
This upgrade is significant for a small-cap hospital stock, as it indicates enhanced earnings prospects, operational efficiencies, or sector tailwinds that have improved the company’s investment appeal. The positive revision in rating is likely a key driver behind the surge in trading volumes and price appreciation observed on 25 Sep.
Technical Strength and Moving Averages
From a technical perspective, Artemis Medicare’s price action is notably strong. The stock is trading comfortably above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, a classic indicator of sustained upward momentum. The new 52-week high of ₹366.5 hit during the session confirms the breakout from previous resistance levels, potentially attracting momentum traders and institutional buyers.
The open gap-up of over 10% further emphasises the bullish sentiment, often signalling fresh buying interest and a possible start of a new uptrend phase. Investors should monitor volume patterns and price consolidation to gauge the sustainability of this rally.
Valuation and Market Context
While Artemis Medicare’s market cap places it in the small-cap category, its recent performance and upgrade suggest it is gaining traction among investors seeking growth opportunities in the healthcare sector. The hospital industry continues to benefit from rising healthcare demand, increased medical infrastructure spending, and favourable demographic trends, which provide a supportive backdrop for companies like Artemis Medicare.
However, investors should remain cautious of volatility inherent in small-cap stocks and monitor broader sector dynamics and regulatory developments that could impact valuations.
Get the full story on Artemis Medicare Services Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Hospital small-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
Investor Takeaway and Outlook
Artemis Medicare Services Ltd’s strong value turnover and institutional interest on 25 Sep 2026 highlight its emergence as a key small-cap stock to watch within the hospital sector. The combination of a recent Mojo Grade upgrade, technical breakout to new highs, and outperformance relative to sector peers suggests a positive near-term outlook.
Investors should consider the stock’s liquidity profile and trading patterns, noting the decline in delivery volumes which may indicate short-term speculative activity. Nonetheless, the overall market sentiment and fundamental improvements support a constructive view on Artemis Medicare’s growth prospects.
As the healthcare sector continues to evolve, companies demonstrating operational resilience and growth potential like Artemis Medicare are likely to attract sustained investor interest. Monitoring quarterly earnings, sector developments, and institutional buying trends will be crucial for assessing the stock’s trajectory going forward.
Summary of Key Metrics:
- Market Cap: ₹5,791.63 crores (Small Cap)
- Mojo Score: 78.0 (Buy, upgraded from Hold on 8 Jun 2026)
- Total Traded Volume: 67.81 lakh shares
- Total Traded Value: ₹247.56 crores
- Day’s High: ₹374.6
- Last Traded Price (LTP): ₹367.6
- Open Gap Up: 10.16%
- Sector Outperformance: +11.12% vs Hospital sector decline of -1.08%
Given these factors, Artemis Medicare Services Ltd stands out as a compelling small-cap stock exhibiting strong trading momentum and institutional backing in the current market environment.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
